InMed Pharmaceuticals, Inc. Stock Price - IMLFF

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
InMed Pharmaceuticals, Inc. IMLFF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 0.27 0.279 0.251 0.251 0.27 10:41:08
Bid Price Ask Price Spread Spread % News
0.27 0.2725 0.0025 0.92% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
60 65,706 $ 0.269490 $ 17,707 267,006 0.217 - 0.82
Last Trade Time Type Quantity Stock Price Currency
10:41:08 2,450 $ 0.27 USD

InMed Pharmaceuticals, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 46.48M 172.13M $ -8.52M - -5.45 135.52M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

InMed Pharmaceuticals, Inc. News

Latest IMLFF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IMLFF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.2710.28280.2440.259076k381k196k-0.001-0.37%
1 Month0.351880.351880.2440.281176k580k255k-0.08188-23.27%
3 Months0.4390.4490.2440.333876k697k269k-0.169-38.50%
6 Months0.2220.6270.2170.398376k2M390k0.04821.62%
1 Year0.6350.820.2170.480176k2M462k-0.365-57.48%
3 Years0.07231.950.050.62593k8M647k0.1977273.44%
5 Years0.561.950.050.6030158M413k-0.29-51.79%

InMed Pharmaceuticals, Inc. Description

InMed Pharmaceuticals is a biopharmaceutical company developing a proprietary biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids, as well as a pipeline of cannabinoid-based medications that target diseases with high unmet medical needs. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. For more information, visit

Your Recent History
InMed Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.